Correlation Between PDS Biotechnology and Actinium Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Actinium Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Actinium Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Actinium Pharmaceuticals, you can compare the effects of market volatilities on PDS Biotechnology and Actinium Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Actinium Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Actinium Pharmaceuticals.
Diversification Opportunities for PDS Biotechnology and Actinium Pharmaceuticals
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between PDS and Actinium is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Actinium Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Actinium Pharmaceuticals and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Actinium Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Actinium Pharmaceuticals has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Actinium Pharmaceuticals go up and down completely randomly.
Pair Corralation between PDS Biotechnology and Actinium Pharmaceuticals
Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the Actinium Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, PDS Biotechnology Corp is 1.03 times less risky than Actinium Pharmaceuticals. The stock trades about -0.19 of its potential returns per unit of risk. The Actinium Pharmaceuticals is currently generating about -0.1 of returns per unit of risk over similar time horizon. If you would invest 179.00 in Actinium Pharmaceuticals on August 25, 2025 and sell it today you would lose (46.00) from holding Actinium Pharmaceuticals or give up 25.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
PDS Biotechnology Corp vs. Actinium Pharmaceuticals
Performance |
| Timeline |
| PDS Biotechnology Corp |
| Actinium Pharmaceuticals |
PDS Biotechnology and Actinium Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PDS Biotechnology and Actinium Pharmaceuticals
The main advantage of trading using opposite PDS Biotechnology and Actinium Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Actinium Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actinium Pharmaceuticals will offset losses from the drop in Actinium Pharmaceuticals' long position.| PDS Biotechnology vs. Actinium Pharmaceuticals | PDS Biotechnology vs. Xilio Development | PDS Biotechnology vs. LAVA Therapeutics NV | PDS Biotechnology vs. OnKure Therapeutics, |
| Actinium Pharmaceuticals vs. PDS Biotechnology Corp | Actinium Pharmaceuticals vs. LAVA Therapeutics NV | Actinium Pharmaceuticals vs. Xilio Development | Actinium Pharmaceuticals vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |